We are pleased to announce the Cold Spring Harbor Asia conference on Cancer Immunotherapy which will be held in Suzhou, China, located approximately 60 miles west of Shanghai. The conference will begin at 7:00pm on the evening of Monday September 7, and will conclude in the evening after banquet on Thursday September 10, 2026.
The conference will include eight oral sessions and one poster session covering the latest findings across many topics in Cancer Immunotherapy. Many talks will be selected from the openly submitted abstracts on the basis of scientific merit and relevance. Social events throughout the conference provide ample opportunity for informal interactions.
Major Topics:
1. Tumor Immune Escape and immunosuppression
2. Primary and Acquired Resistance to Cancer Immunotherapy
3. Targeting Cell Death for Cancer Immunotherapy
4. Cytokine, Antibody and Cell Engineering in Cancer Immunotherapy
5. Cancer Vaccines
6. Integrative Strategies in Cancer Immunotherapy
7. New Approaches to Cancer Immunotherapy
Keynote Speakers:
Philip Greenberg, University of Washington
Judy Lieberman, Harvard Medical School
Invited Speakers:
Andrea Ablasser, Ecole Polytechnique Fédérale de Lausanne
Scott Abrams, Roswell Park Comprehensive Cancer Center
Gabrielle Belz, The University of Queensland Diamantina Institute
Xuetao Cao, Chinese Academy of Medical Sciences
Kenji Chamoto, Center for Cancer Immunotherapy and Immunobiology
Sidonia Fagarasam, Kyoto University
Yang-xin Fu, Tsinghua University
Thomas Gajewski, University of Chicago
Bo Huang, Chinese Academy of Medical Sciences
Guido Kroemer, Centre de Recherche des Cordeliers
Vijay Kuchroo, Harvard Medical School
Kok Haw Jonathan Lim, The Francis Crick Institute
Xin Lin, Tsinghua University
Takeuchi Osamu, Kyoto University
Carlos-Filipe Pereira, Lund University
Yang Pu, Chinese Academy of Medical Sciences
Arlene Sharpe, Harvard Medical School
Ruihua Xu, Sun Yat-sen University
Hongtao Yu, Westlake University
Zemin Zhang, Peking University
Yingming Zhao, University of Chicago
Laurence Zitvogel, Gustave Roussy Cancer Campus
Weiping Zou, University of Michigan
We encourage abstracts to contain new and unpublished materials. The abstracts must be submitted electronically by the abstract deadline. Selection of material for oral and poster presentation will be made by the organizers. Status (fellow's talk/poster) of abstracts will be posted on our web site as soon as decisions have been made by the organizers.
Fellowship:
We are eager to have as many young people as possible attend since they are likely to benefit most from this meeting. A certain number of presentations by graduate students and postdocs in this conference will be selected as fellowship (USD $100-$500) awards. For more details, please visit Stipends
We look forward to seeing you at Suzhou in September, 2026.